Is anyone aware of any companies that have had similar needles at surface, only to end up with an uneconomic resource? I know it's a very specific question, and probably a long shot, but would be curious as to whether it warrants as much excitement as it's generating or whether it could be a point of exaggeration.
Just considering the flip side to temper expectations that are growing increasingly with each announcement.
Institutional buying, page-58
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
